Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2006 Feb;61(2):100-4.
doi: 10.1136/thx.2004.037978.

Inhaled corticosteroids and decline of lung function in community residents with asthma

P Lange  1 , H Scharling, C S Ulrik, J Vestbo
Affiliations

Inhaled corticosteroids and decline of lung function in community residents with asthma

P Lange et al. Thorax. 2006 Feb.

Abstract

Background: Inhaled corticosteroids (ICS) constitute the cornerstone of treatment for asthma. Many studies have reported beneficial short term effects of these drugs, but there are few data on the long term effects of ICS on the decline in forced expiratory volume in 1 second (FEV(1)). This study was undertaken to determine whether adults with asthma treated with ICS have a less pronounced decline in FEV(1) than those not treated with ICS.

Methods: Two hundred and thirty four asthmatic individuals from a longitudinal epidemiological study of the general population of Copenhagen, Denmark were divided into two groups; 44 were treated with ICS and 190 were not treated with ICS. The annual decline in FEV(1) was measured over a 10 year follow up period.

Results: The decline in FEV(1) in the 44 patients receiving ICS was 25 ml/year compared with 51 ml/year in the 190 patients not receiving this treatment (p<0.001). The linear regression model with ICS as the variable of interest and sex, smoking, and wheezing as covariates showed that treatment with ICS was associated with a less steep decline in FEV(1) of 18 ml/year (p = 0.01). Adjustment for additional variables including age, socioeconomic status, body mass index, mucus hypersecretion, and use of other asthma medications did not change these results.

Conclusions: Treatment with ICS is associated with a significantly reduced decline in ventilatory function.

PubMed Disclaimer

Conflict of interest statement

Competing interests: HS has no conflict of interest. PL, CSU and JV have acted as consultants to and received travel grants from AstraZeneca, Boehringer Ingelheim, and GlaxoSmithKline. None of the analyses in this paper was funded by these companies.

Comment in

References

    1. Lange P, Parner J, Vestbo J.et al A 15‐year year follow‐up study of ventilatory function in adults with asthma. N Engl J Med 19983391194–1200. - PubMed
    1. Peat J K, Woolcock A J, Cullen K. Rate of decline of lung function in subjects with asthma. Eur J Respir Dis 198770171–179. - PubMed
    1. Ulrik C S. Outcome of asthma: longitudinal changes in lung function. Eur Respir J 199913904–918. - PubMed
    1. Beckett A, Howarth P H. Pharmacotherapy and airway remodelling in asthma? Thorax 200358163–174. - PMC - PubMed
    1. Trigg C J, Manolitsas N D, Wang J.et al Placebo‐controlled immunopathologic study of four months of inhaled corticosteroids in asthma. Am J Respir Crit Care Med 199415017–22. - PubMed

Publication types

Substances